logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Finally, some common sense

19 October 2010

Lord Young’s review of the operation of health and safety laws and the growth of the compensation culture contains recommendations that should cause schools to breathe a sigh of relief.

Lord Young notes there has been an overzealous approach towards health and safety decreasing the number of educational opportunities for children such as participating in competitive sports and school trip. The threat of legal action should an accident happen has rippled through schools.

Lord Young’s recommendations include a single consent form covering all activities a child undertakes while at school, simplified risk assessments for the classroom, a simplified process for children going on school trips and a shift from a system of risk-assessment to risk-benefit. The changes have been endorsed by the government and many are set to be implemented in January 2011. Finally, it seems common sense is making a comeback.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mark Blois

Mark Blois

Partner and Head of Education

View profile

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up